Anglo Asian Mining Share Discussion Threads

[wanobi] 24/9/2020 07:53

wowzer, thanx for the heads up guys, SKIN, CORA, VRS, ORPH, EVG to watch now :-) Cheers Wan :-)

[pogue] 24/9/2020 07:52

Inaminute
not signed the contract but ORPH is the only supplier of CV19 challenge studies in the world, wonder if they will win it :0)

[katsy] 24/9/2020 07:48

SKIN have announce their real time breathalyzer covid test this morning. Would be interested to see if it's sell on news or re-rating.

[avsome1968] 24/9/2020 07:39

Further Positive Metallurgical Testwork Results

Cora Gold Limited, the West African focused gold company, is pleased to announce the metallurgical testwork results from oxide samples taken from its Sanankoro Gold Project in Southern Mali ('Sanankoro' or 'the Project'). These results follow on from previous work reported on 21 October 2019. The purpose of this testwork was to advance the previous testwork and assess the impact of reagent consumption, residence time, gravity recovery and grind size.

Highlights

-- 94.1% average overall recovery was achieved

-- 44% average recovery from gravity

-- Over 90% leach recoveries within 4 hours leach time

-- demonstrating very quick kinetics and significantly shorter than previous testwork programmes

-- Cyanide consumption was varied with an average consumption of 0.17kg/t

-- significantly less than previous testwork programmes

-- Samples were selected to represent different depth profiles across the oxide deposits of Selin, Zone A and B at
Sanankoro

-- 279kg of oxide material was tested across the three deposits

-- A gravity and Carbon in Leach ('CIL') flowsheet was used to determine the recovery of gold
Bert Monro, CEO, comments "The results from this metallurgical test programme are excellent. A significant proportion of the gold in the Sanankoro ore can be recovered with gravity with over 90% of the remaining gold leaching from the gravity tails within 4 hours. The quick kinetics should reduce the size of the required leach circuit considerably resulting in a capital saving. Further, a significantly reduced cyanide consumption should also have a favourable impact on operating costs. These results will be used in a trade-off between a conventional gravity & CIL flowsheet and heap leach once ongoing column leach testwork is completed. The outcome from the trade-off will be used as the basis of a definitive feasibility study ('DFS') to commence next year."

[wanobi] 24/9/2020 07:39

Cheers
Wan :-)

[wanobi] 24/9/2020 07:36

Good Morning all, Good Luck and great Health to you all on this fine, but soggy UK morning :-) Cheers Wan :-)

ORPH - what lark's guys,,, will be watching, good luck all :-) Cheers Wan :-)

EVG - we have a new CEO at last Rb,,, but, does that mean we're not in play as we thought me wonders!! we shall see in time :-)

Cheers
Wan :-)

[inaminute] 24/9/2020 07:24

Contract not signed yet but there has been massive media exposure for the company in the last 24 hours. Going to be an interesting morning.

[pogue] 24/9/2020 07:15

RB
yes he has been told to tone his exuberance before but this is not his doing hey ho its all there, just wait...

[pogue] 24/9/2020 07:13

CV19 bingo call as expected from ORPH surprisingly damping down speculation, they proved my figures wrong its £7 million per Challenge study not £4 million happy to be corrected. Makes annual income £252 million if all 3 wards are full for the year :0) and they are suggesting they need to expand.



Open Orphan plc (ORPH), a rapidly growing specialist CRO pharmaceutical services company which is the world leader in the testing of vaccines and antivirals using human challenge clinical trials notes the recent share price movement and press speculation regarding UK government-funded Coronavirus human challenge studies.

The Company confirms that it is in advanced negotiation with the UK Government and other partners for a Coronavirus challenge study in the UK. While negotiations continue, it is expected that in the event that a contract is agreed revenue will be in excess of GBP7 million, being the approximate anticipated revenue for a Coronavirus challenge study as indicated by the Company on 22 May 2020. However, there can be no certainty that these discussions will lead to a new contract until final negotiations are concluded. The Company will update the market in due course as appropriate.

Further to its announcements of 9 March 2020 and 22 May 2020 regarding the development by the Company of a Coronavirus challenge study model the Company remains in ongoing discussions with potential vaccine developers regarding Coronavirus challenge studies.

[riggerbeautz] 24/9/2020 07:09

Pogue the brakes might just have been put on.

[bozzy_s] 24/9/2020 00:35

Relieved to see the shares rebound after a few horrible days.

Results were decent - we already knew roughly what the numbers would be, taking into account below-par production and a higher metals price.

The two key points were the nicely increased dividend (I'd expected 4c plus a small 'special') and, critically, production guidance maintained for the year. That means Q3 must have been strong - and we'll get that nice update in a few weeks.

I do understand some of the grievances of posters here. One which we're probably almost unanimous on is firing share price Angel. The small extra cost of hiring a better Nomad / broker is fine.

Actually the company made $2 per oz above spot price in H1. So about $60,000 better than expected. Why not spend that extra cash on a top-notch broker / PR firm?

Ultimately if it came down to it, if everyone feels strongly about the issue, we could between us force it through. Hopefully won't need to - hopefully AAZ continue to read this BB.

So it's a well done from me AAZ. And keep getting better. Start with fixing the hopeless Nomad.

I've personally been very lucky with dividends this year. Nearly everyone is cutting or cancelling. I've got AAZ raising, and FXPO paying its 6th divi of the year in October, adding up to a total of 26p. Market hasn't properly valued either company.

[jbravo2] 24/9/2020 00:33

Boom
I had a few pints to that tonight
:)

[mattjos] 24/9/2020 00:19

We're likely to be sitting on circa $40m cash by end December. On today's valuation, that is about 21% of the market cap!
There's another net $30m in the Tailings dam waiting to be recovered.

for those of us still holding all our shares since the dividends started, that will total over 15p/share received come November & looks set to continue to grow thru 2021.

Gawd knows what the market is waiting for before it fully appreciates just how absurdly cheap the shares are.

Anyway, I am sure that once the Conroy JV is inked and we start to get some drill results in from Ireland, a speculative frenzy will arrive here, despite people seeming to miss the company already advising:

"The Company is now focusing its main geological exploration programme on five mineral discoveries at Gedabek which can be fast-tracked into production, with production scheduled to commence from new mines in 2022. These are Avshancli 1 and 3, Gilar, Ugur Deep and Zefer. Drilling in H1 2020 at these new discoveries was encouraging with high grade intersections of up to 14 g/t of gold encountered. Development drilling in the existing Gadir underground mine also demonstrated the potential for further expansion of this mine."

[katsy] 23/9/2020 23:06

Cinoid, this has been my saying for years

"If your scared of dying then you're scared of living, you may as well be dead!"

[cinoib] 23/9/2020 22:50

Mattjos, don't loose sleep over it, they are well known for taking donkeys over anything, must be getting on for 20 years now since they started prospecting and still nothing to show for it.

Lefrene, Yes is getting expensive, but if all hell breaks loose and c20 or 21 turns up, will be the safest place to be, away from large populations. As I have no doubt that the next virus will be a killer.
Is very weird behaviour today at the gold market with money being printed like it's going out of fashion and the $ about to nose dive and gold drops $40 very weird.

[riggerbeautz] 23/9/2020 22:10

Yeah Pogue I remember Cathal being a smooth talker but having some substance in the offing behind his charm. In truth I got to the point this year where I thought these Covid jumps could retrace hard, not many have so far. Anyway I just stuck with EVG because I had a sense Bumpa was onto something and it was brewing; sadly it’s a slow brew. Could quite easily have stuck with Orph as both are more than just Covid stocks.

[saturdaygirl] 23/9/2020 21:32

Clive Maund from 12 Aug

[mattjos] 23/9/2020 21:26

cracking photo at start of presentation:

[wanobi] 23/9/2020 21:22

beautiful :-) Cheers Wan :-)


free stock charts from uk.advfn.com

[henwii] 23/9/2020 21:20

JBravo,

Thanks for the response, that makes total sense. Thanks for pointing it out. It has not lead to me selling a single share and I still hold 6 figures worth of shares. Looking forward to the Jorc in the next 10 days or so! lots of news to come could be very exciting indeed.

[bonio10000] 23/9/2020 21:15

Fair play

At 100 day support - so will be interesting from here.

[pogue] 23/9/2020 21:13

RBChances are there will be a little retrace in ORPH there always is as Instis top slice regular may go up tomorrow with an RNS though. Have a look it has a lot of income streams and some drugs to sell.

[mattjos] 23/9/2020 21:07

bonio, probably more true to say that chartists are like buses. A Chart is a chart & there is only ever one of them for a stock.
Short term chart analysis is always difficult. i do prefer longer term